Overview
Updated 14 Jul 2026
Sankar Dass Navaneethan, MD, is Garabed Eknoyan MD Endowed Professor of Medicine at Baylor College of Medicine, Houston, TX. The public record shows 452 publications with 44,855 citations (h-index 80), centered on Chronic Kidney Disease and Diabetes, Dialysis and Renal Disease Management, Diabetes Treatment and Management. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 16 companies, 1 NIH-funded awards (2014–2015).
- Most recent indexed publication: 2026 · The Journal of clinical endocrinology and metabolism
- Top research focus: Chronic Kidney Disease and Diabetes
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 16 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 224.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- CRIC-Visceral Adiposity and Physical Fitness in Chronic Kidney Disease
Sponsor: Baylor College of Medicine
InvestigatorCompletedNCT02405650 - Effects of Intentional Weight Loss Interventions in Chronic Kidney Disease
Sponsor: The Cleveland Clinic
InvestigatorPhase 2/PHASE3CompletedNCT01180101
Industry payments
Updated 14 Jul 2026
16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Alnylam Pharmaceuticals Inc.Program year20258 payments$34,165openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202516 payments$12,130openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year20256 payments
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2014–2015 per NIH RePORTER. The latest:
- MENTORED PATIENT-ORIENTED RESEARCH TOWARDS OPTIMIZING CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE
Baylor College of Medicine
FY2025$117,491K24HL161414 - Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease
Michael E Debakey Va Medical Center
FY2025I01HX002917 - MENTORED PATIENT-ORIENTED RESEARCH TOWARDS OPTIMIZING CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE
Baylor College of Medicine
FY2024$117,640K24HL161414
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Impact of SGLT2 Inhibitors on Glomerular Filtration in Type 1 Diabetes.
The Journal of clinical endocrinology and metabolism
2026 - Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.
Hypertension (Dallas, Tex.
2026 - Cardiovascular Outcomes and Acute Kidney Injury Risk with Combination Therapies in Type 2 Diabetes and Chronic Kidney Disease.
Nephrology, dialysis, transplantation
2026 - Expanding Evidence for Glucagon-Like Peptide-1 Receptor Agonists in Those with Diabetes and Kidney Disease.
Clinical journal of the American Society of Nephrology
2026 - Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease.
International journal of nephrology and renovascular disease
2026
Most-cited worksby citation count (OpenAlex)
- 01
- 02
- 03Heart Disease and Stroke Statistics—2021 Update5,782 citations2021
- 04
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Jewish Institute for Research, Room 100D37, Houston, TX 77030
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership rolesjournal and society appointments
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bcm.edu ↗
- Associate Editor
American Journal of Kidney Diseases
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗
Secondary affiliationsappointments beyond the home institution
- Chief
Renal Section, Michael E. DeBakey VA Medical Center, Houston, TX
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houston.hsrd.research.va.gov ↗ - Co-lead
Resources Module, Consortium for Translational and Precision Health, Baylor College of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →prnewswire.com ↗
Media & interviewspress, podcasts and appearances
- ASN Podcast / nephSAP Guest Editor Interview: "ESKD: A Therapeutic Triumph of Nephrology" with Alice Sheridan
MD and Martina McGrath, MD (nephSAP Vol. 24, No. 4)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/sankar-navaneethan-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/sankar-dass-navaneethan-039589249
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Other
kidney.org/press-room/houston-s-sankar-dass-navaneethan-md-ms-mph-named-nkf-s-garabed-eknoyan-award-winner
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗ - ResearchGate
researchgate.net/scientific-contributions/Sankar-D-Navaneethan-50097170
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗ - Doximity
Doximity profile listing: Nephrology, Houston, TX
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
- 1,431
- publications
- 164
- h-index
- 8
- trials
Toni Choueiri, MD
Brigham and Women's Hospital
- 2,494
- publications
- 152
- h-index
- 12
- trials
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
- 1,588
- publications
- 150
- h-index
- 18
- trials
Fred Saad, MD
Centre Hospitalier de l’Université de Montréal
- 1,915
- publications
- 128
- h-index
- 7
- trials